Cargando…
Engineering of Phage-Derived Lytic Enzymes: Improving Their Potential as Antimicrobials
Lytic enzymes encoded by bacteriophages have been intensively explored as alternative agents for combating bacterial pathogens in different contexts. The antibacterial character of these enzymes (enzybiotics) results from their degrading activity towards peptidoglycan, an essential component of the...
Autor principal: | São-José, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023083/ https://www.ncbi.nlm.nih.gov/pubmed/29565804 http://dx.doi.org/10.3390/antibiotics7020029 |
Ejemplares similares
-
Correction: São-José, C. Engineering of Phage-Derived Lytic Enzymes: Improving Their Potential as Antimicrobials. Antibiotics 2018, 7, 29
por: São-José, Carlos
Publicado: (2018) -
Phage Lytic Enzymes
por: Briers, Yves
Publicado: (2019) -
Phage-Derived Peptidoglycan Degrading Enzymes: Challenges and Future Prospects for In Vivo Therapy
por: Oliveira, Hugo, et al.
Publicado: (2018) -
Specific targeting and killing of Gram-negative pathogens with an engineered phage lytic enzyme
por: Lukacik, Petra, et al.
Publicado: (2013) -
Using phage Lytic Enzymes to Control Pathogenic Bacteria
por: Fischetti, Vincent A
Publicado: (2006)